中国精神分裂症的全基因组关联分析及其转化医学进展

被引：10

作者：

李胜 ^{[1
]}

张爱萍 ^{[1
]}

贺林 ^{[1
,2
]}

机构：

[1] 上海交通大学Bio-X研究院,上海交通大学遗传发育与精神神经疾病教育部重点实验室

[2] 复旦大学生物医学研究院

来源：

中国科学:生命科学 | 2013年 / 43卷 / 01期

关键词：

精神分裂症; 全基因组关联分析; 转化医学;

D O I：

暂无

中图分类号：

R749.3 [精神分裂症];

学科分类号：

摘要：

我国在精神分裂症的遗传学和生命组学研究方面取得了很大进展,如在全基因组关联分析(genome-wide association study,GWAS)方面工作获得了一系列成果.随着我国对重大疾病转化医学的逐步关注和重视,利用在精神分裂症上已经获得的广泛和深入的研究结果,寻找精神分裂症各种临床应用的生物标记物研究,系统性地建立适合于类似精神分裂症这类复杂疾病的早期诊断、干预和预防的临床咨询和应用体系等将是该疾病转化医学方面可实施的方法和案例.精神分裂症的转化医学方面还涉及精神分裂症患者的个体化用药方案建立.药物疗效和药物不良反应的个体差异具有较复杂的环境和遗传背景,结合精神分裂症的遗传学病因和药物作用的遗传学差异,将有效发挥治疗药物的功效,并降低重大不良反应在敏感个体上的发生.对精神分裂症这类给国家和社会带来极其重大负担的重大疾病,积极推动我国在此类疾病上的基础研究成果转化和转化医学的实施具有重要的社会效应和积极的带动作用.

引用

页码：31 / 38

页数：8

共 18 条

[1] A pharmacogenetic study of risperidone on histamine H3 receptor gene (HRH3) in Chinese Han schizophrenia patients
Wei, Zhiyun
Wang, Lei
Zhang, Mengmeng
Xuan, Jiekun
Wang, Yang
Liu, Baocheng
Shao, Liyan
Li, Jun
Zeng, Zhen
Li, Tao
Liu, Jie
Wang, Ti
Zhang, Ming
Qin, Shengying
Xu, Yifeng
Feng, Guoyin
He, Lin
Xing, Qinghe
[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (06) : 813 - 818
[2] Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia
Li, Xue Feng
Zheng, You Lan
Xiu, Mei Hong
Chen, Da Chun
Kosten, Thomas R.
Zhang, Xiang Yang
[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (04) : 1064 - 1067
[3] The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia
Xiong, Peng
Zeng, Yong
Wan, Jing
Huang, Diana XiaoHan
Tan, Deyong
Lu, Jin
Xu, Fei
Li, Hong Yi
Zhu, Zuxin
Ma, Mingxing
[J]. PSYCHIATRY RESEARCH, 2011, 189 (01) : 72 - 76
[4] Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (CURES-104)[J] . R Subashini,M Deepa,R Padmavati,R Thara,V Mohan.Journal of Postgraduate Medicine . 2011 (4)
[5] Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia[J] . Peng Xiong,Yong Zeng,Zuxin Zhu,Deyong Tan,Fei Xu,Jin Lu,Jing Wan,Mingxing Ma.Schizophrenia Research . 2010 (1)
[6] Increased serum S100B in never-medicated and medicated schizophrenic patients[J] . Xiang Yang Zhang,Mei Hong Xiu,Cai Song,Da Chun Chen,Gui Ying Wu,Colin N. Haile,Therese A. Kosten,Thomas R. Kosten.Journal of Psychiatric Research . 2010
[7] Pharmacogenetics and Schizophrenia
Foster, Adriana
Miller, Del D.
Buckley, Peter
[J]. CLINICS IN LABORATORY MEDICINE, 2010, 30 (04) : 975 - +
[8] Decreased levels of serum brain-derived neurotrophic factor in drug-na?ve first-episode schizophrenia: relationship to clinical phenotypes[J] . Da Chun Chen,Jing Wang,Bo Wang,Sheng Chang Yang,Chong Xi Zhang,You Lan Zheng,Yan Li Li,Ning Wang,Ke Bing Yang,Mei Hong Xiu,Thomas R. Kosten,Xiang Yang Zhang.Psychopharmacology . 2009 (3)
[9] Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients
Wei, Zhiyun
Wang, Lei
Xuan, Jiekun
Che, Ronglin
Du, Jing
Qin, Shengying
Xing, Yi
Gu, Bo
Yang, Lun
Li, Huafang
Li, Jun
Feng, Guoyin
He, Lin
Xing, Qinghe
[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (03) : 547 - 551
[10] Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers[J] . Gerald St&ouml,ber,Dorit Ben-Shachar,M. Cardon,Peter Falkai,Alfred N. Fonteh,Micha Gawlik,Birte Y. Glenthoj,Edna Gr&uuml,nblatt,Assen Jablensky,Yong-Ku Kim,Johannes Kornhuber,Thomas F. McNeil,Norbert M&uuml,ller,Bob Oranje,Toshikazu Saito,Mohamed Saoud,Andrea Schmitt,Michal Schwartz,Johannes Thome,Marat Uzbekov,Nuria Durany,Peter Riederer.World Journal of Biological Psychiatr

← 1 2 →